Novartis digs deeper into cancer with up to $750 million Aduro deal

(Reuters) - Swiss drugmaker Novartis is digging deeper into cancer immunotherapy, one of the hottest areas of drug research, through a tie-up with Aduro Biotech worth up to $750 million.

from Reuters: Deals http://ift.tt/1bJPUO4